Operating Expenses Summary of PharmaEngine, Inc.

PharmaEngine, Inc.'s latest annual operating expenses in 2023 was 441.78 Million TWD , up 37.23% from previous year.
PharmaEngine, Inc.'s latest quarterly operating expenses in 2024 Q2 was 106.66 Million TWD , up 23.97% from previous quarter.
PharmaEngine, Inc. reported a annual operating expenses of 321.93 Million TWD in annual operating expenses 2022, up 26.11% from previous year.
PharmaEngine, Inc. reported a annual operating expenses of 255.28 Million TWD in annual operating expenses 2021, up 22.1% from previous year.
PharmaEngine, Inc. reported a quarterly operating expenses of 86.04 Million TWD for 2024 Q1, down -22.71% from previous quarter.
PharmaEngine, Inc. reported a quarterly operating expenses of 156.81 Million TWD for 2023 Q3, up 56.77% from previous quarter.

Annual Operating Expenses Chart of PharmaEngine, Inc. (2023 - 2009)

Historical Annual Operating Expenses of PharmaEngine, Inc. (2023 - 2009)

Year	Operating Expenses	Operating Expenses Growth
2023	441.78 Million TWD	37.23%
2022	321.93 Million TWD	26.11%
2021	255.28 Million TWD	22.1%
2020	209.07 Million TWD	-16.25%
2019	249.63 Million TWD	4.84%
2018	238.1 Million TWD	0.1%
2017	237.87 Million TWD	-26.73%
2016	324.65 Million TWD	87.57%
2015	173.08 Million TWD	14.3%
2014	151.43 Million TWD	-3.34%
2013	156.66 Million TWD	28.34%
2012	122.06 Million TWD	75.86%
2011	69.41 Million TWD	-24.52%
2010	91.95 Million TWD	-13.45%
2009	106.24 Million TWD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	106.66 Million TWD	23.97%
2024 Q1	86.04 Million TWD	-22.71%
2023 Q3	156.81 Million TWD	56.77%
2023 Q4	111.32 Million TWD	-29.01%
2023 FY	441.78 Million TWD	37.23%
2023 Q1	73.61 Million TWD	-23.78%
2023 Q2	100.03 Million TWD	35.9%
2022 Q1	45.85 Million TWD	-24.8%
2022 Q2	57.37 Million TWD	25.1%
2022 Q3	122.13 Million TWD	112.89%
2022 Q4	96.57 Million TWD	-20.93%
2022 FY	321.93 Million TWD	26.11%
2021 Q1	72.11 Million TWD	-4.35%
2021 Q2	54.07 Million TWD	-25.02%
2021 Q3	68.12 Million TWD	25.99%
2021 Q4	60.98 Million TWD	-10.48%
2021 FY	255.28 Million TWD	22.1%
2020 Q3	45.26 Million TWD	0.18%
2020 Q2	45.18 Million TWD	4.52%
2020 FY	209.07 Million TWD	-16.25%
2020 Q1	43.23 Million TWD	-27.18%
2020 Q4	75.39 Million TWD	66.55%
2019 Q3	60.32 Million TWD	-14.32%
2019 FY	249.63 Million TWD	4.84%
2019 Q4	59.36 Million TWD	-1.59%
2019 Q2	70.4 Million TWD	18.27%
2019 Q1	59.53 Million TWD	0.1%
2018 Q2	53.47 Million TWD	-10.39%
2018 Q3	65.48 Million TWD	22.47%
2018 FY	238.1 Million TWD	0.1%
2018 Q4	59.46 Million TWD	-9.19%
2018 Q1	59.67 Million TWD	-40.34%
2017 Q1	47.38 Million TWD	-62.3%
2017 Q3	33.3 Million TWD	-41.74%
2017 Q2	57.15 Million TWD	20.61%
2017 Q4	100.03 Million TWD	200.39%
2017 FY	237.87 Million TWD	-26.73%
2016 FY	324.65 Million TWD	87.57%
2016 Q4	125.69 Million TWD	55.47%
2016 Q3	80.85 Million TWD	-4.14%
2016 Q2	84.33 Million TWD	149.72%
2016 Q1	33.77 Million TWD	-27.39%
2015 FY	173.08 Million TWD	14.3%
2015 Q4	46.51 Million TWD	17.39%
2015 Q3	39.62 Million TWD	-28.03%
2015 Q2	55.05 Million TWD	72.63%
2015 Q1	31.89 Million TWD	-51.64%
2014 Q3	33.58 Million TWD	12.58%
2014 Q2	29.83 Million TWD	35.14%
2014 Q1	22.07 Million TWD	-33.39%
2014 FY	151.43 Million TWD	-3.34%
2014 Q4	65.93 Million TWD	96.33%
2013 Q3	73.98 Million TWD	183.16%
2013 Q1	23.41 Million TWD	4.63%
2013 Q2	26.12 Million TWD	11.6%
2013 Q4	33.14 Million TWD	-55.21%
2013 FY	156.66 Million TWD	28.34%
2012 Q3	65.69 Million TWD	255.8%
2012 Q4	22.37 Million TWD	-65.94%
2012 Q2	18.46 Million TWD	18.46%
2012 FY	122.06 Million TWD	75.86%
2012 Q1	15.58 Million TWD	-12.13%
2011 Q2	19 Million TWD	-4.4%
2011 FY	69.41 Million TWD	-24.52%
2011 Q4	17.73 Million TWD	38.78%
2011 Q1	19.88 Million TWD	0.0%
2011 Q3	12.78 Million TWD	-32.76%
2010 FY	91.95 Million TWD	-13.45%
2009 FY	106.24 Million TWD	0.0%

Peer Operating Expenses Comparison of PharmaEngine, Inc.

Name	Operating Expenses	Operating Expenses Difference
Anti-Microbial Savior BioteQ Co., Ltd	329 Thousand TWD	-134182.371%
SYN-TECH Chem. & Pharm. Co., Ltd.	127.67 Million TWD	-246.04%
Level Biotechnology Inc.	151.99 Million TWD	-190.664%
Sagittarius Life Science Corp	135.85 Million TWD	-225.196%
NeoCore Technology Co., Ltd.	75.85 Million TWD	-482.382%
TaiMed Biologics Inc.	225.23 Million TWD	-96.148%
GlycoNex Incorporation	995 Thousand TWD	-44300.905%
VBI	32.55 Million TWD	-1257.054%
GeneReach Biotechnology Corp.	256.86 Million TWD	-71.99%
Taiwan Advance Bio-Pharmaceutical Inc.	194.18 Million TWD	-127.508%
SynCore Biotechnology Co.,Ltd	46.02 Million TWD	-859.931%
Genomics BioSci & Tech. Co.,Ltd.	119.91 Million TWD	-268.434%
Visgeneer Inc.	67.48 Million TWD	-554.677%
Mycenax Biotech Inc.	-375.19 Million TWD	217.75%
Sunmax Biotechnology Co., Ltd.	510.09 Million TWD	13.391%
G&E Herbal Biotechnology Co., Ltd.	63.9 Million TWD	-591.343%
Neith Corporation	66.87 Million TWD	-560.639%
Medigen Vaccine Biologics Corporation	1.44 Billion TWD	69.406%
TaiwanJ Pharmaceuticals Co., Ltd.	29.35 Million TWD	-1405.141%
Enimmune corporation	220.1 Million TWD	-100.72%
TaiRx, Inc.	217.13 Million TWD	-103.464%
CHO Pharma, Inc.	268.99 Million TWD	-64.235%
EirGenix Inc.	236.74 Million TWD	-86.613%
BioLASCO Taiwan Co., Ltd.	104.35 Million TWD	-323.368%
Sunny Pharmtech Inc.	357.62 Million TWD	-23.535%
Lin BioScience, Inc.	1.09 Billion TWD	59.721%
BioGend Therapeutics Co., Ltd.	266.15 Million TWD	-65.987%
Feng Chi Biotech Corp.	49.47 Million TWD	-793.026%
Bio Preventive Medicine Corp.	1.08 Million TWD	-40693.075%
Lukas Biomedical Inc.	177.45 Million TWD	-148.965%
RBC Bioscience Corporation	58.35 Million TWD	-657.058%
BiOptic Inc.	108.69 Million TWD	-306.46%
BRIM Biotechnology, Inc.	90 Thousand TWD	-490776.667%
Shine-On BioMedical Co.,Ltd.	69.35 Million TWD	-537.043%
Great Novel Therapeutics Biotech & Medicals	2.61 Million TWD	-16794.417%
Syngen Biotech Co.,Ltd.	643.91 Million TWD	31.39%
Advagene Biopharma Co., Ltd.	93.33 Million TWD	-373.332%
NaviFUS Corp.	11.82 Million TWD	-3635.427%
Gwo Xi Stem Cell Applied Technology Co. , Ltd	190.72 Million TWD	-131.632%
Sinew Pharma Inc.	186.25 Million TWD	-137.198%
Andros Pharmaceuticals Co.,Ltd	74.02 Million TWD	-496.827%
Greenyn Biotechnology Co., Ltd	220.39 Million TWD	-100.451%
Lumosa Therapeutics Co., Ltd.	41.48 Million TWD	-965.039%
AP Biosciences Inc	32.25 Million TWD	-1269.761%
Medigen Biotechnology Corp.	1.85 Billion TWD	76.125%
3D Global Biotech Inc.	5.27 Million TWD	-8276.735%
Pharmosa Biopharm Inc.	317.32 Million TWD	-39.223%
Intech Biopharm Corporation	-163.99 Million TWD	369.392%
Oneness Biotech Co., Ltd.	1.12 Billion TWD	60.875%
Eusol Biotech Co.,Ltd.	41.48 Million TWD	-965.014%
TWi Biotechnology, Inc.	169.55 Million TWD	-160.556%
Ever Supreme Bio Technology Co., Ltd	147.02 Million TWD	-200.492%
TCI GENE Inc.	174.61 Million TWD	-153.005%
MegaPro Biomedical Co., Ltd	18 Thousand TWD	-2454283.333%
Senhwa Biosciences, Inc.	300.93 Million TWD	-46.804%
Taiwan Bio Therapeutics Co., Ltd	290.95 Million TWD	-51.84%
NatureWise Biotech & Medicals Corporation	83.94 Million TWD	-426.284%
Savior Lifetec Corporation	223.36 Million TWD	-97.784%
TaiGen Biopharmaceuticals Holdings Limited	258.77 Million TWD	-70.721%
OBI Pharma, Inc.	2.01 Billion TWD	78.089%
Meribank Biotech Co., Ltd	138.87 Million TWD	-218.131%
Acepodia, Inc.	452.56 Million TWD	2.382%
Caliway Biopharmaceuticals Co., Ltd.	540.93 Million TWD	18.329%

Global Stocks Search

PharmaEngine, Inc. (4162.TWO)

Operating Expenses Summary of PharmaEngine, Inc.

Annual Operating Expenses Chart of PharmaEngine, Inc. (2023 - 2009)

Historical Annual Operating Expenses of PharmaEngine, Inc. (2023 - 2009)

Peer Operating Expenses Comparison of PharmaEngine, Inc.